Vaxcyte, Inc. (PCVX) has a market capitalization of $9.03B and trades at $62.76. The 52-week range is 27.66-65.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -11.1, Earnings Per Share (EPS) of $-5.63.
The stock has a beta of 1.39, operates in the Healthcare sector.
